Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7672)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2019 (publication date) through May 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Baratta F, Pastori D, Ferro D, Carluccio G, Tozzi G, Angelico F, Violi F, Del Ben M. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? World J Gastroenterol 2019; 25(30): 4172-4180 [PMID: 31435171 DOI: 10.3748/wjg.v25.i30.4172] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i30/4172.htm |
| Number | Citing Articles |
| 1 |
Ioannis Tsomidis, George Notas, Argyro Voumvouraki, Dimitrios Samonakis, Mairi Koulentaki, Elias Kouroumalis. Hepatic Lysosomal Enzyme Activity in Primary Biliary Cholangitis. Fibrosis 2023; 1(1): 1 doi: 10.35534/fibrosis.2023.10005
|
| 2 |
Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Research 2022; 6(2): 72 doi: 10.1016/j.livres.2022.05.002
|
| 3 |
Shuo Zhang, Bing Ji, Changqing Yang, Li Yang. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis. 2023; doi: 10.5772/intechopen.108168
|
| 4 |
Zhengzheng Zhang, Madhulika Singh, Alida Kindt, Agnieszka B. Wegrzyn, Mackenzie J. Pearson, Ahmed Ali, Amy C. Harms, Paul Baker, Thomas Hankemeier. Development of a targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry based lipidomics platform applied to a coronavirus disease severity study. Journal of Chromatography A 2023; 1708: 464342 doi: 10.1016/j.chroma.2023.464342
|
| 5 |
Hirokazu Kanegane, Atsuko Noguchi, Yuki Yamada, Takahiro Yasumi. Rare diseases presenting with hemophagocytic lymphohistiocytosis. Pediatrics International 2023; 65(1) doi: 10.1111/ped.15516
|
| 6 |
Saloni Sinha, Nora Hassan, Robert E. Schwartz. Organelle stress and alterations in interorganelle crosstalk during liver fibrosis. Hepatology 2024; 79(2): 482 doi: 10.1097/HEP.0000000000000012
|
| 7 |
Lin An, Mi Zhang, Yuefang Lin, Ting Jiang, Keyang Xu, Shilin Xiao, Liming Cai, Hiu Yee Kwan, Zhongqiu Liu, Tao Su. Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression. Phytomedicine 2022; 103: 154199 doi: 10.1016/j.phymed.2022.154199
|
| 8 |
Haejin Yoon, Jillian L. Shaw, Marcia C. Haigis, Anna Greka. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. Molecular Cell 2021; 81(18): 3708 doi: 10.1016/j.molcel.2021.08.027
|
| 9 |
Elias Badal Rashu, Anders Ellekær Junker, Karen Vagner Danielsen, Emilie Dahl, Ole Hamberg, Line Borgwardt, Vibeke Brix Christensen, Nicolai J Wewer Albrechtsen, Lise L Gluud. Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. World Journal of Clinical Cases 2020; 8(9): 1642-1650 doi: 10.12998/wjcc.v8.i9.1642
|
| 10 |
Amal A. Aqul, Charina M. Ramirez, Adam M. Lopez, Dennis K. Burns, Joyce J. Repa, Stephen D. Turley. Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease. Lipids 2022; 57(1): 3 doi: 10.1002/lipd.12325
|
| 11 |
Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin. Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease. Liver International 2020; 40(2): 271 doi: 10.1111/liv.14311
|
| 12 |
Fat’hiya Al-Harthy, Neha Kamath, Lee Hill, Jelena Popov, Allison Bossert, Herbert Brill, Nikhil Pai. Evaluation of Hepatitis in Pediatric Patients With Presumed Nonalcoholic Fatty Liver Disease. JPGN Reports 2022; 3(2): e181 doi: 10.1097/PG9.0000000000000181
|
| 13 |
Pilar Giraldo, Laura López de Frutos, Jorge J Cebolla. Recommendations for overcoming challenges in the diagnosis of lysosomal acid lipase deficiency. Expert Opinion on Orphan Drugs 2022; 10(1): 11 doi: 10.1080/21678707.2022.2131393
|
| 14 |
Yunpeng Bai, Wendong Huang, Yaocai Li, Changchun Lai, Sumei Huang, Guangwen Wang, Yuemei He, Linhui Hu, Chunbo Chen. Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry. Bioscience Reports 2021; 41(3) doi: 10.1042/BSR20204305
|
| 15 |
Rutiane Ullmann Thoen, Larisse Longo, Santiago Cassales Neto, Mário Reis Álvares-da-Silva. Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101638 doi: 10.1016/j.clinre.2021.101638
|
| 16 |
Christian L. Horn, Amilcar L. Morales., Christopher Savard, Geoffrey C Farrell, George N. Ioannou. Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH. Hepatology Communications 2022; 6(1): 12 doi: 10.1002/hep4.1801
|
| 17 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|
| 18 |
Zhengzheng Zhang, Naama Karu, Alida Kindt, Madhulika Singh, Lieke Lamont, Adriaan J. van Gammeren, Anton A. M. Ermens, Amy C. Harms, Lutzen Portengen, Roel C. H. Vermeulen, Willem A. Dik, Anton W. Langerak, Vincent H. J. van der Velden, Thomas Hankemeier. Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients. Biomolecules 2024; 14(3): 296 doi: 10.3390/biom14030296
|
| 19 |
Feifei Li, Xiaojie Zhao, Hao Li, Yu Liu, Yu Zhang, Xiaopeng Huang, Jia Cao, Fen Du, Dongfang Wu, Hong Yu. Hepatic lysosomal acid lipase drives the autophagy-lysosomal response and alleviates cholesterol metabolic disorder in ApoE deficient mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(12): 159027 doi: 10.1016/j.bbalip.2021.159027
|
| 20 |
I. I. Pshenichnikova, I. N. Zakharova, E. V. Skorobogatova, T. I. Bocharova, Yu. V. Koba. Lysosomal acid lipase deficiency – an underestimated cause of hypercholesterolemia in children. Meditsinskiy sovet = Medical Council 2022; (1): 250 doi: 10.21518/2079-701X-2022-16-1-250-255
|
| 21 |
Katrina J. Besler, Valentin Blanchard, Gordon A. Francis. Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1013266
|
| 22 |
Ashok Mandala, Rachel C. Janssen, Sirish Palle, Kevin R. Short, Jacob E. Friedman. Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients 2020; 12(10): 3166 doi: 10.3390/nu12103166
|